Manal El-Sayed, MD, is Professor of Pediatrics at Ain Shams University, Cairo, Egypt, where she trained in medicine and subsequently completed her masters and doctorate in Pediatrics. Since 1990 she has worked in pediatric hematology and oncology teams developing a program for the management of liver disease in children with hematological disorders, malignancies and recipients of bone marrow transplantation at Ain Shams University, National Cancer Institute and 57357 Children’s Cancer Hospital.
She is a member of the Egyptian National Committee for Control of Viral Hepatitis since 2006 charged with planning and implementing a program for prevention and management of viral hepatitis. She contributed to development of the national communication strategy for hepatitis awareness in adults (including hepatitis B vaccination) and children in collaboration with various organisations, including Johns Hopkins.
Professor El-Sayed authored and co-authored numerous journal articles on hepatitis and liver diseases. She is an active board member and secretary general of the Egyptian Liver Care Society, a non-governmental organisation supporting needy patients undergoing liver transplantation or treatment of hepatitis.
She is also the clinical director of the national HCV Pediatric treatment program. Since 2011 Professor El-Sayed has been appointed as Vice Chair of the WHO’s Technical Advisory Group for Prevention and Control of Viral Hepatitis in Egypt 2012 through 2018 and by the Minister of Health as the supervisor of the Egyptian national program for control of viral hepatitis at Ministry of Health.